[go: up one dir, main page]

ES2072536T3 - Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica. - Google Patents

Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica.

Info

Publication number
ES2072536T3
ES2072536T3 ES91300461T ES91300461T ES2072536T3 ES 2072536 T3 ES2072536 T3 ES 2072536T3 ES 91300461 T ES91300461 T ES 91300461T ES 91300461 T ES91300461 T ES 91300461T ES 2072536 T3 ES2072536 T3 ES 2072536T3
Authority
ES
Spain
Prior art keywords
elevated
therapeutics
present anti
thiazolidine derivatives
hypertensive activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91300461T
Other languages
English (en)
Inventor
Hiroyoshi Horikoshi
Toshihiko Fujiwara
Shinji Yoshioka
Hiroshi Nishino
Hiroyuki Koike
Takao Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2072536T3 publication Critical patent/ES2072536T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

FORMULA DEL DERIVADO DE TIAZOLIDINA. (EN LA CUAL: R ELEVADO A 1, R ELEVADO A 2, R ELEVADO A 4, R ELEVADO A 5 SON CADA UNA HIDROGENO O ALQUILO; Y R ELEVADO A 3 ES HIDROGENO, ACILO ALIFATICO, ALCOXICARBONILO, O ARILCARBONILO) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES SON AGENTES ANTI-HIPERTENSIVOS Y SON UTILES EN EL TRATAMIENTO DE HIPERTENSION RELACIONADO CON LA OBESIDAD Y PARA LA PREPARACION DE USOS PARA TAL TRATAMIENTO.
ES91300461T 1990-01-22 1991-01-22 Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica. Expired - Lifetime ES2072536T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1232190 1990-01-22

Publications (1)

Publication Number Publication Date
ES2072536T3 true ES2072536T3 (es) 1995-07-16

Family

ID=11802053

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91300461T Expired - Lifetime ES2072536T3 (es) 1990-01-22 1991-01-22 Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica.

Country Status (11)

Country Link
US (1) US5614542A (es)
EP (1) EP0439321B1 (es)
JP (1) JP2826379B2 (es)
KR (1) KR0163052B1 (es)
AT (1) ATE119773T1 (es)
AU (1) AU637182B2 (es)
CA (1) CA2034616A1 (es)
DE (1) DE69108067T2 (es)
DK (1) DK0439321T3 (es)
ES (1) ES2072536T3 (es)
FI (1) FI910303A7 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175179A (en) * 1991-09-25 1992-12-29 Pfizer Inc. Method for treating hypertension
FI961213L (fi) * 1993-09-15 1996-05-14 Sankyo Co Tiatsolidinidionien käyttö insuliinista riippumattoman sokeritaudin syntymisen ehkäisemiseksi tai viivyttämiseksi
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
CZ298812B6 (cs) 1996-07-01 2008-02-13 Dr. Reddy's Laboratories Limited Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
TW577875B (en) * 1997-01-31 2004-03-01 Shionogi & Co Pyrrolidine derivatives with inhibitory activity for phospholipase A2
EP0981526B1 (en) * 1997-05-02 2004-02-25 Dr. Reddy's Laboratories Ltd. Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
DK173350B1 (da) * 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
US4933355A (en) * 1988-04-14 1990-06-12 Sankyo Company Limited Thiazole derivatives, their preparation and their use in the treatment of diabetes complications
DE3823533A1 (de) * 1988-07-12 1990-02-08 Beiersdorf Ag Substituierte 4-heterocyclyl-2h-benzo(b)pyrane, verfahren und 4-hydroxy-3-brom-, 3,4-oxiranyl-3,4-dehydro-2h-benzo(b)pyrane als zwischenprodukte zu ihrer herstellung, sowie sie enthaltende pharmazeutsche praeparate
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension

Also Published As

Publication number Publication date
JPH03251530A (ja) 1991-11-11
JP2826379B2 (ja) 1998-11-18
FI910303L (fi) 1991-07-23
US5614542A (en) 1997-03-25
EP0439321A3 (en) 1992-04-01
DE69108067D1 (de) 1995-04-20
KR910014119A (ko) 1991-08-31
KR0163052B1 (ko) 1998-12-01
FI910303A7 (fi) 1991-07-23
AU637182B2 (en) 1993-05-20
HK1006284A1 (en) 1999-02-19
ATE119773T1 (de) 1995-04-15
DK0439321T3 (da) 1995-07-24
AU6948091A (en) 1991-07-25
FI910303A0 (fi) 1991-01-21
CA2034616A1 (en) 1991-07-23
DE69108067T2 (de) 1995-11-02
EP0439321B1 (en) 1995-03-15
EP0439321A2 (en) 1991-07-31

Similar Documents

Publication Publication Date Title
ES2072536T3 (es) Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica.
DK51986A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som insecticide midler
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
FR2698543B1 (fr) Nouvelles compositions à base de taxoides.
MX9300603A (es) Derivados tiaciclicos de piperidinilo.
HUP0003929A2 (hu) Piperazinszármazékok és alkalmazásuk gyulladásgátló hatású gyógyszerkészítmények előállítására, valamint a vegyületeket tartalmazó gyógyszerkészítmények
ES2188584T3 (es) Derivados heterociclicos de amina.
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
ES2175161T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
PA8442201A1 (es) Derivados de 6-fenilpiridil-2-amina
ES2051772T3 (es) 2-sustituido-e-fusionado-(1,2,4)-triazol(1,5-c)pirimidinas, composiciones farmaceuticas y sus usos.
ES2087477T3 (es) Derivados de pirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
ES2123873T3 (es) Pirrolocarbazol.
AR007997A1 (es) Un derivado de distamicina sustituida con acriloilo, sus utilizaciones, un procedimiento para producirlo y una composicion farmaceutica que lo comprende.
UY25211A1 (es) Inhibidores de isoquinolinilguanidina uroquinasa
ES2059534T3 (es) Nuevos derivados benzopiranos antihipertensivos.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
PE296A1 (es) Derivados de 2-imidazolina-5-onas fungicidas
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
ES2039719T3 (es) Procedimiento para preparar un agente terapeutico para el tratamiento de la enfermedad de ulcera peptica.
ES2059396T3 (es) Derivados de indeno y metodos.
AR003812A1 (es) Uso de los compuestos de 2-fenil-3-benzoil-benzotiofeno-6-sustituidos y sus sales farmaceuticamente aceptables para inhibir el inhibidor de activacion delplasminogeno 1.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 439321

Country of ref document: ES